![](/img/cover-not-exists.png)
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
Margolis, David A, Gonzalez-Garcia, Juan, Stellbrink, Hans-Jürgen, Eron, Joseph J, Yazdanpanah, Yazdan, Podzamczer, Daniel, Lutz, Thomas, Angel, Jonathan B, Richmond, Gary J, Clotet, Bonaventura, GutiLanguage:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(17)31917-7
Date:
July, 2017
File:
PDF, 804 KB
english, 2017